GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GSK PLC (MEX:GSK N) » Definitions » Ending Cash Position

GSK (MEX:GSK N) Ending Cash Position : MXN112,362 Mil (As of Mar. 2025)


View and export this data going back to 2003. Start your Free Trial

What is GSK Ending Cash Position?

GSK's Ending Cash Position for the quarter that ended in Mar. 2025 was MXN112,362 Mil.

GSK's quarterly Ending Cash Position increased from Sep. 2024 (MXN78,865 Mil) to Dec. 2024 (MXN89,724 Mil) and increased from Dec. 2024 (MXN89,724 Mil) to Mar. 2025 (MXN112,362 Mil).

GSK's annual Ending Cash Position declined from Dec. 2022 (MXN81,332 Mil) to Dec. 2023 (MXN61,408 Mil) but then increased from Dec. 2023 (MXN61,408 Mil) to Dec. 2024 (MXN89,724 Mil).

GSK Ending Cash Position Historical Data

The historical data trend for GSK's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GSK Ending Cash Position Chart

GSK Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 140,687.77 104,179.48 81,332.28 61,408.10 89,724.33

GSK Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 54,575.74 67,103.79 78,865.38 89,724.33 112,361.51

GSK Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

GSK's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=75354.729+14369.604
=89,724

GSK's Ending Cash Position for the quarter that ended in Mar. 2025 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=89947.358+22414.151
=112,362

GSK Ending Cash Position Related Terms

Thank you for viewing the detailed overview of GSK's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

GSK Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GSK PLC (MEX:GSK N) » Definitions » Ending Cash Position
Comparable Companies
LSE:AZN LLY JNJ ABBV OCSE:NOVO B XSWX:ROG XSWX:NOVN MRK AMGN PFE GILD XPAR:SAN BMY TSE:4519 TSE:4568 SHSE:600276 XTER:BAYN TSE:4578 BIIB TSE:4503
Traded in Other Exchanges
GLAXF:USA GSK:USA GSK1:Mexico GSKl:UK GSK:UK GS70:Germany GS71:Germany GS71:Germany GS71:Germany GS70:Germany GS71:Germany G1SK34:Brazil GSK:Argentina
Address
79 New Oxford Street, London, GBR, WC1A 1DG
Website
https://www.gsk.com
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.

GSK Headlines

No Headlines